May 17, 2021
Removal of retained central venous access ports represents a significant challenge. In this paper, we describe two case reports involving two diametrically different strategies for managing retained port-a-caths (PACs). The decision in both cases is guided by a multidisciplinary assessment of the need for extraction of the port and the risk of procedural complications.
In both cases, a prolonged PAC indwelling period represented the main factor predisposing to retention. In the first case, involving an infected and retained 11-year-old PAC, we performed a complete port system extraction using cardiac electrophysiology extraction tools. In the second case, in the presence of discomfort only over the reservoir site of a retained 9-year-old port system, a consensus decision was made to excise the reservoir from the catheter and cap the residual tubing with a low-profile pacemaker lead cap. There were no procedural complications.
Retained PACs can be prevented by the timely removal of PACs that are no longer in use. When PAC removal with manual traction is difficult, a multidisciplinary evaluation is vital to address the absolute need to extract retained PACs. Using cardiac pacemaker lead management as a model, strategies in dealing with retained PACs can include complete removal of the reservoir-catheter system in the presence of infection versus abandoning non-functional or extraneous implants. A revision strategy consisting of removing the reservoir and capping the catheter with a low-profile cardiac pacemaker lead is a safe option that can achieve satisfactory cosmetic results.
retained port-a-cath; transvenous catheter extraction; cardiac pacemaker leads
Totally implantable central venous access devices (port-a-caths) are commonly used to administer prolonged chemotherapy regimens, antibiotic therapy, transfusion of blood products, parenteral nutrition, and repeated blood sampling. The port-a-cath (PAC) is a combination of a subcutaneous reservoir (port) and an intravascular device (catheter) (Figure 1). The intravascular catheter is inserted in a central vein (usually the jugular vein or subclavian vein) and tunneled under the skin of the chest wall, and connected to the subcutaneous port. The port has a chamber with a silicone membrane that can be accessed by puncturing the overlying skin with an injecting needle.
Figure 1. Port-a-cath system (BARD)
The specific timing for PAC removal varies according to indications and treatment duration and is not well established. However, it is generally considered that PACs that are no longer in use should be removed as prolonged indwelling periods can result in fibrosis and adhesion of the catheters to the central venous system and may make them difficult to remove with manual traction.1,2
In this article, we report two cases of stuck polyurethane PAC catheters that were not able to be removed with manual traction and describe management options, including extraction with cardiac pacemaker lead removal tools as well as a strategy of revision and abandonment.
In the first case, a 71-year-old male with a history of a left subclavian vein PAC placement 11 years prior for lymphoma treatment presented with pancytopenia and was found to have acute myeloid leukemia. During the hospitalization, he developed recurrent high-grade Staphylococcus epidermidis catheter-related bacteremia. PAC removal was attempted using an open technique with manual traction at the bedside and in the operating room; however, the intravascular catheter remained stuck into the central vein. Subsequently, the patient was referred to the cardiac electrophysiology service for extraction of the retained port.
Bilateral femoral venous access was obtained to provide one site for cannulation of the catheter and another site for the lead extractor. After the pectoral pocket was opened, the catheter was dissected down to just under the clavicle and the entry into the subclavian vein. The end of the catheter was freed of the clot, and a hydrophilic-wire (0.35"" in GLIDEWIRE, Terumo Interventional Systems) was passed through the catheter distally to clear the lumen. Once the lumen was clear, the GLIDEWIRE was substituted for a standard stiff 0.035""in J-wire that was passed through the catheter into the superior vena cava to stiffen the plastic tubing; 0-Silk ties were securely tied around the distal end of the tubing. A bulldog lead extender (Cook Medical) was also placed around the distal tubing to achieve a firm grip of the catheter. We passed 14, and 16 French GlideLight laser sheaths (Spectranetics) over the catheter assembly.
Still, a heavy calcified fibrous sheath was present around the catheter and prevented the laser sheath's advancement. Subsequently, we substituted the laser sheaths with a Byrd dilator sheath (Cook Medical) (Figure 2). Then, using a combination of sheath rotation and traction, we were ultimately able to liberate the catheter from the subclavian vein and remove it (Figure 3).
Figure 2. Fluoroscopic anterior-posterior view showing the Byrd dilator sheath (arrow) around the catheter in the left subclavian vein
Figure 3. Extracted 11-year-old port catheter. Note areas of residual fibrous sheath encapsulating the catheter and the bulldog lead extender (Cook Medical) used to secure the catheter and facilitate removal through the sheath (arrow).
Five months after the procedure, the patient was doing well, without any complications related to the port removal.
In the second case, a 71-year-old female with a history of a left internal jugular vein port placement nine years prior for the administration of chemotherapy for lung cancer was referred for surgical PAC removal because of complaints of discomfort at the reservoir site. Despite dissection down to the insertion site in the subclavian vein, the catheter was firmly adherent to the vasculature and unable to be removed despite robust manual traction. Subsequently, a consensus decision of the surgery and electrophysiology teams was made to revise the port-catheter system, an approach that we label a strategy of revision and abandonment. Thus, the reservoir was cut from the tubing and removed to relieve patient discomfort at the site, and a standard Medtronic pacemaker lead cap (Figure 3) was placed on the end of the tubing and secured with a 2-0 Silk tie.
The remaining portion of the catheter was replaced in the subcutaneous pocket, and the incision subsequently closed. After three months, the patient was doing well without any catheter-related complications.
A retained intravenous catheter is a rare complication associated with the placement of totally implantable venous access devices. The incidence of retained catheters in pediatric populations has been reported between 0.3 and 2.2 percent. It has been associated with longer times since initial placement, type of medications administered (chemotherapeutic agents), and catheter materials (polyurethane versus silicone) 3–5). Although the adult literature is not as broad as in the pediatric population, the incidence of retained catheters is also low (<1 percent).6 A duration in situ exceeding two years is considered the most critical risk factor for retained catheters.7
In our cases, the ports remained in place for 11 and 9 years, respectively, representing the main factor predisposing to retention.
Presumably, fixation of long-term intravenous catheters is caused by calcification of the fibrin sheath formed around the catheter8,9 and bridging from the vein wall to the catheter.10
This rare complication represents a significant challenge as these catheters could be stuck within major vascular structures such as the jugular vein, subclavian vein, the superior vena cava, and even within the heart. When attempting to remove retained ports with simple manual traction, it is prudent to avoid forceful traction of the catheter to prevent complications such as fragmentation of the catheter with subsequent migration and vascular injuries.
Various alternative techniques have been used to facilitate the extraction of retained catheters when careful manual traction is not successful. They range in invasiveness from various endovascular methods (such as balloon dilators, loop-snares, basket retrievers, and pigtails11–13) to complicated open surgical interventions (such as intra-periosteal clavicle resections with subclavian venorrhaphy and neck exploration with jugular venorrhaphy.14) As these complex techniques are associated with increased potential for complications, it is essential to address the absolute need to extract the retained port in cases where it will not move with traction near the vein entry site.
In this paper, we describe two case reports involving two diametrically different strategies for managing retained PACs. The decision in both cases is guided by a multidisciplinary assessment of the need for PAC extraction. In the first case, in the presence of port infection, we decided to perform a complete port system extraction using cardiac electrophysiology extraction tools, a well-described approach.15 Evidence suggests that antibiotic treatment alone is not successful in eradicating the intra-vascular device infection. The formation of a biofilm on infected indwelling vascular catheters' surface has a critical role in bacterial antimicrobial resistance and recalcitrant infections as biofilm bacteria can survive high concentrations of antibiotics.16,17 Catheter-related infection is considered a strong indication for PAC removal and is the most common complication that results in device removal.18,19
In the second case, discomfort over the reservoir site was the only device-related symptom. In the absence of an absolute indication for complete port system extraction, a multidisciplinary decision was made to revise the reservoir and abandon the catheter, a technique that has not been described previously to the best of our knowledge. The port pocket was opened, the reservoir excised from the catheter tubing, and residual tubing was capped and secured in the pocket to prevent potential migration. This technique avoids potential risks of extraction, which could include vessel trauma and incomplete extraction from catheter fracture or dehiscence. Furthermore, removing the reservoir leads to normalization of the chest wall's topography. This reasonable cosmetic result may be important to some patients. The cosmetic results can be further enhanced by capping the catheter with a low-profile pacemaker lead cap.
Abandoning intravascular catheters has a theoretical risk for potential complications such as migration or thrombus in the future. In our opinion, catheter migration is unlikely as they are well fixed to the vein wall to the point of being unable to be manually removed. Nevertheless, to prevent the migration risk, we recommend suturing the catheter's external end on the pectoralis fascia. The long-term risk of thrombus formation is unknown but appears to be very low based on evidence from patients with retained pacemaker wires.20 In both cases, we reported, patients did well for approximately a decade without developing catheter-related thrombosis. Surveillance with Doppler ultrasound can be used to detect catheter-related clots in patients with elevated thrombotic risk.
A multidisciplinary evaluation is important to address the absolute need to extract retained ports in cases when they are difficult to remove with manual traction. Using cardiac pacemaker lead management as a model, strategies in dealing with retained ports can include complete removal of the reservoir-catheter system in the presence of infection versus abandoning non-functional or extraneous implants. A revision strategy consisting in the removal of the reservoir and capping of the catheter with a low-profile cardiac pacemaker lead is a safe option that can achieve satisfactory cosmetic results.
Timely removal of PACs that are no longer in use is important for preventing their retention. Cardiac pacemaker lead management could serve as a model in dealing with retained ports that cannot be extracted with manual traction, but only after a multidisciplinary assessment of the absolute need for their removal.
Hoffmeister PSa; Muñoz-Largacha JAb,c; Stolarski Ab,c; Kristo Gb,d
Gentian Kristo, MD, MPH, FACS
Veterans Affairs Boston Healthcare System
Department of Surgery
1400 VFW Parkway
West Roxbury, Boston, MA 02132
E-mail: gentian.kristo@va.gov
The authors have no conflicts of interest to disclose.